Pittenger & Anderson Inc. Increases Position in Intuitive Surgical, Inc. $ISRG

Pittenger & Anderson Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 60,282 shares of the medical equipment provider’s stock after acquiring an additional 140 shares during the period. Intuitive Surgical comprises approximately 1.2% of Pittenger & Anderson Inc.’s portfolio, making the stock its 18th largest position. Pittenger & Anderson Inc.’s holdings in Intuitive Surgical were worth $32,758,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Chilton Capital Management LLC increased its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. The Goldman Sachs Group lowered their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research note on Wednesday, October 1st. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Mizuho lowered their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating for the company in a research note on Tuesday, October 14th. Finally, Truist Financial lowered their price objective on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating for the company in a research note on Wednesday, October 15th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $580.29.

Intuitive Surgical Price Performance

ISRG stock opened at $458.47 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market cap of $164.35 billion, a P/E ratio of 63.94, a PEG ratio of 4.69 and a beta of 1.61. The firm has a 50-day moving average of $454.70 and a 200 day moving average of $495.81.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.